SELECTA BIOSCIENCES
Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.
SELECTA BIOSCIENCES
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.selectabio.com
Total Employee:
51+
Status:
Active
Contact:
(617) 923-1400
Email Addresses:
[email protected]
Total Funding:
320.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx
Current Advisors List
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Current Employees Featured
![]()

![]()
![]()
![]()
![]()
![]()
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Selecta Biosciences
![]()
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Selecta Biosciences
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Post-IPO Equity - Selecta Biosciences
Polaris Partners
Polaris Partners investment in Series E - Selecta Biosciences
Sanofi Ventures
Sanofi Ventures investment in Series E - Selecta Biosciences
![]()
Sphera Funds Management
Sphera Funds Management investment in Series E - Selecta Biosciences

Eminent Venture Capital
Eminent Venture Capital investment in Series E - Selecta Biosciences
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series E - Selecta Biosciences
![]()
Leukon Investments
Leukon Investments investment in Series E - Selecta Biosciences
I2BF Global Ventures
I2BF Global Ventures investment in Series E - Selecta Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-06 | Cyrus Biotechnology | Selecta Biosciences investment in Series B - Cyrus Biotechnology | 18 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-20 | Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer |
Official Site Inspections
http://www.selectabio.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
